Markel Group Inc. (MKL) Stock Analysis
Falling Knife setup
Financial Services · Insurance - Property & Casualty
Sell if holding. Analyst target reached at $1799.48 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: concentrated equity securities portfolio (70.0%).
Markel Group is a holding company anchored by Markel Insurance, which provides specialty P&C insurance, plus Markel Ventures owning diverse industrial and consumer businesses. It generated $15.5B in operating revenues in 2025 with $18.6B in shareholders' equity, compounding... Read more
Sell if holding. Analyst target reached at $1799.48 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: concentrated equity securities portfolio (70.0%). Chart setup: Death cross, below all MAs, RSI 29, MACD bearish. Score 4.3/10, moderate confidence.
Passes 4/7 gates (clean insider activity, no SEC red flags, earnings proximity 89d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductconcentrated equity securities portfolio70%10-K Item 1A: 'Equity securities were 70% of our shareholders' equity at December 31, 2025... Our portfolio of equity securities is concentrated in particular issuers and industries'
Material Events(8-K, last 90d)
- 2026-02-26Item 5.02MEDIUMEVP/COO Michael R. Heaton departing March 23, 2026 per mutual agreement, with severance. Simon Wilson appointed EVP/CEO Markel Insurance; Andrew Crowley appointed EVP/President Markel Ventures. COO role not replaced directly.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Revenue shrinking — -16.9% YoY. Growth thesis broken unless recovery story develops.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $1799.48 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: concentrated equity securities portfolio (70.0%). Chart setup: Death cross, below all MAs, RSI 29, MACD bearish. Prior stop was $1693.99. Score 4.3/10, moderate confidence.
Take-profit target: $1971.31 (+9.6% upside). Prior stop was $1693.99. Stop-loss: $1693.99.
Concentration risk — Product: concentrated equity securities portfolio (70.0%); Analyst target reached - limited upside remaining; Weak overall score: 4.3/10.
Markel Group Inc. trades at a P/E of 12.8 (forward 13.9). TrendMatrix value score: 6.8/10. Verdict: Sell.
13 analysts cover MKL with a consensus score of 2.5/5. Average price target: $2039.
What does Markel Group Inc. do?Markel Group is a holding company anchored by Markel Insurance, which provides specialty P&C insurance, plus Markel...
Markel Group is a holding company anchored by Markel Insurance, which provides specialty P&C insurance, plus Markel Ventures owning diverse industrial and consumer businesses. It generated $15.5B in operating revenues in 2025 with $18.6B in shareholders' equity, compounding capital through insurance float invested heavily in equities and by acquiring operating businesses.